Clinical Trials

332 enrolled

Carcinoma, Hepatocellular

NCT04490993 2022-02-22

ACCRUE

359 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT04736394 2022-02-22

ASCERTAIN

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT05121350 2022-02-18

A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma

256 enrolled

Sarcoma

NCT02971345 2020-06-11

Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

253 enrolled

Carcinoma, Hepatocellular

NCT02879513 2020-03-23

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

290 enrolled

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT03876886 2019-03-21

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

200 enrolled

Triple Negative Breast Neoplasms

NCT00301925 2018-08-08

TACT2

4,400 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT01222052 2017-06-26

NNBC3-Europe

4,150 enrolled

Breast Neoplasms

NCT03192644 2017-06-20

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

162 enrolled

Carcinoma, Hepatocellular

NCT03006614 2017-01-16

PERS

320 enrolled

Breast Neoplasms

NCT02630108 2016-10-18

TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma

280 enrolled

Carcinoma, Hepatocellular

NCT02755311 2016-04-28

Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma

198 enrolled

Carcinoma, Hepatocellular

NCT00005581 2013-12-18

Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

1,000 enrolled

Breast Neoplasms

NCT00010140 2013-12-18

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer

Breast Neoplasms

NCT00022178 2013-09-20

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

Tumor-Agnostic

Neoplasms, Unknown Primary

NCT00011921 2013-09-17

Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer

430 enrolled

Thoracic

Lung Neoplasms

NCT01094964 2013-08-12

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

242 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT00070278 2013-08-07

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

Breast Neoplasms

NCT00516425 2013-08-07

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer

1,000 enrolled

Breast Neoplasms

NCT00629278 2013-08-07

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

2,500 enrolled

Breast Neoplasms

NCT01031030 2013-08-02

Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009)

Breast Neoplasms

NCT01378533 2011-12-28

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

100 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01479036 2011-11-24

CBCRT01